Senior Clinical Trial Physician, Oncology at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Serves as primary source of medical accountability and oversight for multiple clinical trials
Manages Phase 1 – Phase 3 studies with demonstrated decision-making capabilities
Provides medical and scientific expertise to cross-functional BMS colleagues
In-depth knowledge of etiology, natural history, diagnosis, and treatment of oncology disorders
Strong expertise in oncology disease area through attending scientific conferences and ongoing literature review
Keeps abreast of development and regulatory issues related to competitive or relevant compounds
Fulfills GCP and compliance obligations for clinical conduct and maintains all required training
Maintains a strong medical/scientific reputation within the oncology disease area

Responsibilities

Medical Monitoring: Leads medical data review of trial data, including eligibility review
Holds responsibility for site interactions in partnership with the Clinical Scientist (CS) for medical questions, education, and safety management guidelines
Holds responsibility for assessment of key safety-related serious adverse events in partnership with Worldwide Patient Safety and oversees safety narratives
Leads collaboration with CS and inputs into protocols, providing medical strategic oversight in protocol development (input on inclusion/exclusion and other safety-related clinical considerations)
Contributes to and is a key member of a high-performing Study Delivery Team (SDT) and may be a member of the Clinical Development Team (CDT)
In collaboration with the Clinical Development Lead, designs and develops clinical plans and protocols with a strong strategic focus based on knowledge of asset/drug, disease area, and relevant science to meet regulatory and disease strategy targets
Provides oversight and medical accountability for a group of studies
Leads the analysis of benefit/risk for clinical development protocols in a matrix team environment working with Clinical Scientists (CS)
Partners with CS to support executional delivery of studies (e.g., site activation, enrollment status, adjudication for protocol violations, significant/non-significant deviations)
Identifies and builds relationships with principal investigators; identifies and cultivates thought leaders for inputs on emerging science in drug and biomarker research, disease knowledge, and design of clinical development studies and programs
Provides ongoing medical education in partnership with collaborating Clinical Scientists to allow for protocol-specific training, supporting the study team, investigators, and others
Matrix management responsibilities across the internal and external network

Skills

Oncology

Clinical Trials

Phase 1 Studies

Phase 2 Studies

Phase 3 Studies

Medical Monitoring

Safety Management

Site Interactions

Data Review

Matrix Management

Cross-functional Leadership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free